Zebrafish shown to be useful tool in prostate cancer stem cell research

November 7, 2013, Rutgers University

(Medical Xpress)—Research from Rutgers Cancer Institute of New Jersey demonstrates that using zebrafish to identify self-renewing tumor stem cells in prostate cancers may be more beneficial than using traditional experimental models when aiming to predict response to therapy.

Prostate cancers are suggested to contain self-renewing tumor stem cells that have the ability to grow uncontrollably and spread. Identified as tumor-initiating cells (TICs), research has shown that these cells are found to be resistant to standard chemotherapy. A desirable treatment strategy is to develop therapies that would effectively target the self-renewing capabilities of the TICs, which requires better identification of TICs themselves. Utilizing samples from patients diagnosed at the Cancer Institute of New Jersey between 2008 and 2012, investigators used mouse and zebrafish models to identify the frequencies of TICs from each patient's . The research appears in the latest edition of The Prostate.

Typically, TICs are identified through more mechanical methods, such as cell sorting or dye staining. Cancer Institute investigators developed a new method to enrich for TICs through remodeling of the environment of in a laboratory setting by allowing them to adhere to collagen – a glue-like protein that holds together skin, connective, and prostate tissues in the human body. In collaboration between multiple Cancer Institute laboratories, prostate tumors cells from patients are first identified with fluorescent markers in the laboratory of Cancer Institute Director, Robert S. DiPaola, professor of medicine at Rutgers Robert Wood Johnson Medical School. These are then enriched for TICs by collagen adhesion at the laboratory of the Cancer Institute Chief Scientific Officer, Joseph R. Bertino, university professor of medicine and pharmacology at Robert Wood Johnson Medical School. The TIC frequencies for these tumor cells are then examined in mice and zebrafish assays.

When these TICs were transplanted into both mice and zebrafish embryos, it was determined that a fraction of the cells that had adhesive properties had the potential for tumor development and for tumor spread. The authors found that this detection was better determined within the zebrafish model, due to its translucent nature allowing for non-invasive observation and also due to lack of immune response to tumor cells. It is a research model senior author and Cancer Institute scientist Hatem E. Sabaawy, says holds great value. "The self-renewing properties found in TICs are regulated through molecular pathways within the cell. By targeting these pathways and using a few from each patient, there may be an opportunity to control progression and recurrence in multiple cancers. The zebrafish model enables researchers to examine this pathway to progression in real time, thus having the potential to serve as a better tool for personalized cancer therapy," noted Dr. Sabaawy, who is also an assistant professor of medicine at Robert Wood Johnson Medical School.

Explore further: Team finds potential clue associated with aggressive prostate cancer

More information: DOI: 10.1002/pros.22740

Related Stories

Team finds potential clue associated with aggressive prostate cancer

August 20, 2013
Prostate cancer is one of the most common forms of cancer in men and the leading cause of cancer deaths in white, African-American and Hispanic men, according to the Centers for Disease Control. Current treatment of prostate ...

Study highlights possible new approach to prostate cancer treatment

August 1, 2013
A study in the Journal of Biological Chemistry identifies a new therapeutic approach to treat prostate cancer.

Researchers track lethal prostate cancer to determine clonal origin

October 26, 2013
Prostate cancer has variable manifestations, ranging from relatively benign localized tumors to widespread life-threatening metastases. The origin of most prostate cancer metastases can be traced back to the primary tumor; ...

Proteins that deliver leucine to prostate cancer cells are therapeutic targets

September 19, 2013
Like normal cells, cancer cells require amino acids for growth, maintenance, and cell signaling, and L-type amino acid transporters (LATs) are the delivery vehicles that supply them. Metastatic, castration-resistant prostate ...

Cancer cells propagated from early prostate cancer

September 25, 2013
A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the ...

New point of attack for breast cancer with poor prognosis

March 5, 2012
(Medical Xpress) -- Scientists from the Friedrich Miescher Institute for Biomedical Research describe how the protein phosphatase SHP2 promotes breast cancer with poor prognosis. As they report in the latest issue of Nature ...

Recommended for you

Researchers discover new anti-cancer protein

March 21, 2018
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from ...

Targeting telomeres to overcome therapy resistance in advanced melanoma

March 21, 2018
A study conducted at The Wistar Institute in collaboration with The University of Texas Southwestern Medical Center has demonstrated the efficacy of targeting aberrantly active telomerase to treat therapy-resistant melanoma. ...

Cancer comes back all jacked up on stem cells

March 19, 2018
After a biopsy or surgery, doctors often get a molecular snapshot of a patient's tumor. This snapshot is important - knowing the genetics that cause a cancer can help match a patient with a genetically-targeted treatment. ...

Researchers create a drug to extend the lives of men with prostate cancer

March 16, 2018
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.